Abstract

Breast ultrasound (BUS) image classification in benign and malignant classes is often based on pre-trained convolutional neural networks (CNNs) to cope with small-sized training data. Nevertheless, BUS images are single-channel gray-level images, whereas pre-trained CNNs learned from color images with red, green, and blue (RGB) components. Thus, a gray-to-color conversion method is applied to fit the BUS image to the CNN's input layer size. This paper evaluates 13 gray-to-color conversion methods proposed in the literature that follow three strategies: replicating the gray-level image to all RGB channels, decomposing the image to enhance inherent information like the lesion's texture and morphology, and learning a matching layer. Besides, we introduce an image decomposition method based on the lesion's structural information to describe its inner and outer complexity. These gray-to-color conversion methods are evaluated under the same experimental framework using a pre-trained CNN architecture named ResNet-18 and a BUS dataset with more than 3000 images. In addition, the Matthews correlation coefficient (MCC), sensitivity (SEN), and specificity (SPE) measure the classification performance. The experimental results show that decomposition methods outperform replication and learning-based methods when using information from the lesion's binary mask (obtained from a segmentation method), reaching an MCC value greater than0.70 and specificity up to0.92, although the sensitivity is about0.80. On the other hand, regarding the proposed method, the trade-off between sensitivity and specificity is better balanced, obtaining about0.88 for both indices and an MCC of0.73. This study contributes to the objective assessment of different gray-to-color conversion approaches in classifying breast lesions, revealing that mask-based decomposition methods improve classification performance. Besides, the proposed method based on structural information improves the sensitivity, obtaining more reliable classification results on malignant cases and potentially benefiting clinical practice.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call